We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
2351
Safehold
SAFE
$1.09B
| $230K | ﹤0.01% |
+2,803
| New | +$328K |
|
|
BBBY
2352
Bed Bath & Beyond
BBBY
$423M
| $229K | ﹤0.01% |
7,517
-7
| -0.1% | -$311 |
|
2353
XPEL
XPEL
$1.31B
| $229K | ﹤0.01% |
5,286
-1,091
| -17% | -$67.4K |
|
|
BHVN
2354
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $229K | ﹤0.01% |
2,564
+155
| +6% | +$19.3K |
|
2355
BlueLinx
BXC
$719M
| $228K | ﹤0.01% |
+3,415
| New | +$280K |
|
2356
Reynolds Consumer Products
REYN
$5.51B
| $228K | ﹤0.01% |
7,715
-219
| -3% | -$6.55K |
|
|
EVBG
2357
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $228K | ﹤0.01% |
5,300
-255,100
| -98% | -$12.1M |
|
|
AGNT
2358
AGNT Inc
AGNT
$715M
| $226K | ﹤0.01% |
16,913
+340
| +2% | +$8.9K |
|
|
EQRX
2359
DELISTED
EQRx, Inc. Common Stock
EQRX
| $226K | ﹤0.01% |
+43,449
| New | +$189K |
|
2360
8x8 Inc
EGHT
$324M
| $224K | ﹤0.01% |
24,407
+12,140
| +99% | +$168K |
|
2361
uniQure
QURE
$3.2B
| $224K | ﹤0.01% |
+14,992
| New | +$262K |
|
2362
DoubleVerify
DV
$2.03B
| $222K | ﹤0.01% |
10,225
-633
| -6% | -$16.5K |
|
|
BBBY
2363
DELISTED
Bed Bath & Beyond Inc
BBBY
| $220K | ﹤0.01% |
16,136
+1,327
| +9% | +$23.1K |
|
|
GBT
2364
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $220K | ﹤0.01% |
7,152
-536
| -7% | -$16K |
|
2365
Relay Therapeutics
RLAY
$4.37B
| $219K | ﹤0.01% |
9,190
-556
| -6% | -$13.5K |
|
2366
Groupon
GRPN
$933M
| $216K | ﹤0.01% |
11,085
+979
| +10% | +$21.8K |
|
2367
Nelnet
NNI
$4.53B
| $215K | ﹤0.01% |
2,620
-52
| -2% | -$4.48K |
|
|
ATRS
2368
DELISTED
Antares Pharma, Inc.
ATRS
| $215K | ﹤0.01% |
45,120
-77,854
| -63% | -$282K |
|
2369
AerSale
ASLE
$274M
| $212K | ﹤0.01% |
+14,647
| New | +$225K |
|
2370
Sutro Biopharma
STRO
$423M
| $212K | ﹤0.01% |
3,534
-13,862
| -80% | -$1.32M |
|
2371
Driven Brands
DRVN
$2.07B
| $211K | ﹤0.01% |
7,577
+1,002
| +15% | +$29K |
|
|
AKRO
2372
DELISTED
Akero Therapeutics
AKRO
| $209K | ﹤0.01% |
19,926
+717
| +4% | +$12.6K |
|
|
TGH
2373
DELISTED
Textainer Group Holdings limited
TGH
| $209K | ﹤0.01% |
6,217
-591
| -9% | -$22.4K |
|
2374
Victory Capital Holdings
VCTR
$6.85B
| $207K | ﹤0.01% |
7,673
-135
| -2% | -$4.41K |
|
|
INVX
2375
Innovex International
INVX
$2.04B
| $206K | ﹤0.01% |
+7,139
| New | +$205K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.